Herpes simplex virus 2 infection impacts stress granule accumulation

J Virol. 2012 Aug;86(15):8119-30. doi: 10.1128/JVI.00313-12. Epub 2012 May 23.

Abstract

Interference with stress granule (SG) accumulation is gaining increased appreciation as a common strategy used by diverse viruses to facilitate their replication and to cope with translational arrest. Here, we examined the impact of infection by herpes simplex virus 2 (HSV-2) on SG accumulation by monitoring the localization of the SG components T cell internal antigen 1 (TIA-1), Ras-GTPase-activating SH3-domain-binding protein (G3BP), and poly(A)-binding protein (PABP). Our results indicate that SGs do not accumulate in HSV-2-infected cells and that HSV-2 can interfere with arsenite-induced SG accumulation early after infection. Surprisingly, SG accumulation was inhibited despite increased phosphorylation of eukaryotic translation initiation factor 2α (eIF2α), implying that HSV-2 encodes previously unrecognized activities designed to maintain translation initiation downstream of eIF2α. SG accumulation was not inhibited in HSV-2-infected cells treated with pateamine A, an inducer that works independently of eIF2α phosphorylation. The SGs that accumulated following pateamine A treatment of infected cells contained G3BP and PABP but were largely devoid of TIA-1. We also identified novel nuclear structures containing TIA-1 that form late in infection. These structures contain the RNA binding protein 68-kDa Src-associated in mitosis (Sam68) and were noticeably absent in infected cells treated with inhibitors of viral DNA replication, suggesting that they arise as a result of late events in the virus replicative cycle.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing / genetics
  • Adaptor Proteins, Signal Transducing / metabolism
  • Animals
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism
  • Chlorocebus aethiops
  • Cytoplasmic Granules / genetics
  • Cytoplasmic Granules / metabolism*
  • Cytoplasmic Granules / pathology
  • Cytoplasmic Granules / virology
  • DNA Helicases
  • DNA Replication / drug effects
  • DNA Replication / physiology*
  • DNA, Viral / biosynthesis*
  • DNA, Viral / genetics
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism
  • Epoxy Compounds / pharmacology
  • Eukaryotic Initiation Factor-2 / genetics
  • Eukaryotic Initiation Factor-2 / metabolism
  • HeLa Cells
  • Herpes Genitalis / genetics
  • Herpes Genitalis / metabolism*
  • Herpes Genitalis / pathology
  • Herpesvirus 2, Human / physiology*
  • Humans
  • Macrolides / pharmacology
  • Phosphorylation / drug effects
  • Poly(A)-Binding Proteins / genetics
  • Poly(A)-Binding Proteins / metabolism
  • Poly-ADP-Ribose Binding Proteins
  • RNA Helicases
  • RNA Recognition Motif Proteins
  • RNA-Binding Proteins / genetics
  • RNA-Binding Proteins / metabolism
  • T-Cell Intracellular Antigen-1
  • Thiazoles / pharmacology
  • Vero Cells
  • Virus Replication / drug effects
  • Virus Replication / physiology*

Substances

  • Adaptor Proteins, Signal Transducing
  • Carrier Proteins
  • DNA, Viral
  • DNA-Binding Proteins
  • Epoxy Compounds
  • Eukaryotic Initiation Factor-2
  • KHDRBS1 protein, human
  • Macrolides
  • Poly(A)-Binding Proteins
  • Poly-ADP-Ribose Binding Proteins
  • RNA Recognition Motif Proteins
  • RNA-Binding Proteins
  • T-Cell Intracellular Antigen-1
  • TIA1 protein, human
  • Thiazoles
  • pateamine A
  • DNA Helicases
  • G3BP1 protein, human
  • RNA Helicases